These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36748811)

  • 1. 4-Nerolidylcatechol (4-NC) and Docetaxel Synergize in Controlling Androgen- independent Prostate Cancer Cells.
    da Silva Guimarães G; Cordeiro AO; Gazolla MC; Vecchi L; Pereira Zoia MA; de Vasconcelos Azevedo FVP; Moreira Campos I; de Souza Costa D; Soares Mota ST; Alves Ribeiro M; Goulart LR; da Silva Filho AA; Araújo TG
    Curr Top Med Chem; 2023; 23(11):943-955. PubMed ID: 36748811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin enhances the susceptibility of both androgen-dependent and -independent prostate carcinoma cells to docetaxel.
    Liu QJ; Xu XH; Shang DH; Tian Y; Lü WC; Zhang YH
    Chin Med J (Engl); 2010 Feb; 123(3):356-60. PubMed ID: 20193259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy.
    Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
    Prostate; 2009 Oct; 69(14):1579-85. PubMed ID: 19575420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization to docetaxel in prostate cancer cells by green tea and quercetin.
    Wang P; Henning SM; Heber D; Vadgama JV
    J Nutr Biochem; 2015 Apr; 26(4):408-15. PubMed ID: 25655047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy.
    Wang P; Henning SM; Magyar CE; Elshimali Y; Heber D; Vadgama JV
    J Exp Clin Cancer Res; 2016 May; 35():73. PubMed ID: 27151407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting lactate dehydrogenase‑A promotes docetaxel‑induced cytotoxicity predominantly in castration‑resistant prostate cancer cells.
    Muramatsu H; Sumitomo M; Morinaga S; Kajikawa K; Kobayashi I; Nishikawa G; Kato Y; Watanabe M; Zennami K; Kanao K; Nakamura K; Suzuki S; Yoshikawa K
    Oncol Rep; 2019 Jul; 42(1):224-230. PubMed ID: 31180564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combination of Omega-3 Stearidonic Acid and Docetaxel Enhances Cell Death over Docetaxel Alone in Human Prostate Cancer Cells.
    Mansour M; van Ginkel S; Dennis JC; Mason B; Elhussin I; Abbott K; Pondugula SR; Samuel T; Morrison E
    J Cancer; 2018; 9(23):4536-4546. PubMed ID: 30519360
    [No Abstract]   [Full Text] [Related]  

  • 8. A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.
    Naito R; Kano H; Shimada T; Makino T; Kadomoto S; Iwamoto H; Yaegashi H; Izumi K; Kadono Y; Nakata H; Saito Y; Goto M; Nakagawa-Goto K; Mizokami A
    Prostate; 2021 Apr; 81(5):295-306. PubMed ID: 33493355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer.
    Begemann D; Wang Y; Yang W; Kyprianou N
    Prostate; 2020 Sep; 80(12):926-937. PubMed ID: 32542812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference.
    Fu YK; Wang BJ; Tseng JC; Huang SH; Lin CY; Kuo YY; Hour TC; Chuu CP
    J Biomed Sci; 2022 Feb; 29(1):16. PubMed ID: 35197069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.
    Mimeault M; Johansson SL; Batra SK
    Br J Cancer; 2013 Mar; 108(5):1079-91. PubMed ID: 23449353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells.
    Shimada T; Naito R; Toriumi R; Nakagawa R; Aoyama S; Kamijima T; Kano H; Kadomoto S; Iwamoto H; Yaegashi H; Izumi K; Kadono Y; Nakata H; Saito Y; Nakagawa-Goto K; Mizokami A
    Anticancer Res; 2023 Jun; 43(6):2433-2444. PubMed ID: 37247901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2-deoxyglucose enhances chemosensitivity of androgen-independent prostate cancer cells to docetaxel].
    Zhou P; Lin YR; Huang MP; Xie KJ; Tang P
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3230-4. PubMed ID: 24405548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells.
    Tolba MF; Esmat A; Al-Abd AM; Azab SS; Khalifa AE; Mosli HA; Abdel-Rahman SZ; Abdel-Naim AB
    IUBMB Life; 2013 Aug; 65(8):716-29. PubMed ID: 23847086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
    Colditz J; Rupf B; Maiwald C; Baniahmad A
    Mol Cell Biochem; 2016 Oct; 421(1-2):139-47. PubMed ID: 27562825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study.
    Shimabukuro T; Sakano S; Matsuda K; Kamiryo Y; Yamamoto N; Kaneda Y; Nasu T; Baba Y; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Konishi M; Imoto K; Matsuyama H
    Int J Clin Oncol; 2013 Feb; 18(1):62-7. PubMed ID: 22068464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.
    Brown SG; Knowell AE; Hunt A; Patel D; Bhosle S; Chaudhary J
    Prostate; 2015 Feb; 75(3):266-79. PubMed ID: 25327819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
    Li X; Wu JB; Chung LW; Huang WC
    Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.
    Marín-Aguilera M; Codony-Servat J; Reig Ò; Lozano JJ; Fernández PL; Pereira MV; Jiménez N; Donovan M; Puig P; Mengual L; Bermudo R; Font A; Gallardo E; Ribal MJ; Alcaraz A; Gascón P; Mellado B
    Mol Cancer Ther; 2014 May; 13(5):1270-84. PubMed ID: 24659820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines.
    Burich RA; Holland WS; Vinall RL; Tepper C; White RW; Mack PC
    BJU Int; 2008 Nov; 102(10):1458-66. PubMed ID: 18565171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.